Tele-Nursing-Supported Mindfetalness: Anxiety and Prenatal Attachment

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorAbant Izzet Baysal University

About this trial

The goal of this clinical trial is to compare the effects of tele-nursing-supported Mindfetalness method versus Mindfetalness alone method on maternal anxiety and prenatal attachment in pregnant women. The main questions it aims to answer are:

* H1: Tele-nursing-supported Mindfetalness method will significantly reduce state anxiety (STAI-S) levels in pregnant women over time compared to Mindfetalness alone method. * H2: Tele-nursing-supported Mindfetalness method will significantly reduce trait anxiety (STAI-T) levels in pregnant women over time compared to Mindfetalness alone method. * H3: Tele-nursing-supported Mindfetalness method will significantly increase prenatal attachment (PAI) levels in pregnant women over time compared to Mindfetalness alone method.

Researches will compare tele-nursing-supported Mindfetalness to Mindfetalness alone to see if tele-nursing support significiantly reduces state and trait anxiety levels and significiantly increases prenatal attachment levels in pregnant women over time.

Participants will;

* Attend a single, face-to-face Mindfetalness training session at the beginning of the study to learn technique and application procedures correctly. * Practice Mindfetalness method daily for 15 minutes throughout the 8-week study period. * Complete a daily compliance tracking chart to record their adherence to the Mindfetalness method of their practice. * Complete the State-Trait Anxiety Inventory (STAI) and the Prenatal Attachment Inventory (PAI) at baseline and during 4th and 8th-week follow-up measurements to track changes over time.

Eligibility criteria

Qualifiers

Aged 18 years or older

Being at the 28th week of gestation

Having a singleton pregnancy

Being primiparous

Disqualifiers

Having a high-risk pregnancy (e.g., preterm labor threat, preeclampsia, gestational diabetes, placenta previa, or cardiac disease).

Presence of diagnosed fetal health complications (e.g., intrauterine growth restriction [IUGR], fetal anomalies).

Currently monitoring fetal movements using any other conventional fetal movement counting methods.

Presence of any communication barriers (e.g., hearing, speech, or language impairments).

Trial design

Treatments tested in this trial

  • Tele-Nursing-Supported Mindfetalness
  • Mindfetalness Alone

Treatment groups

68 Participants
are divided into 2 treatment groups

Sponsors and collaborators